# Recommended Additional Searches for NAC Dosing Information

## 1. Age-Specific Searches

### Neonates and Infants
- **Search:** `N-acetylcysteine neonatal OR infant`
- **Rationale:** Dosing in very young children may differ significantly
- **Focus:** Safety and pharmacokinetics in <1 year

### Adolescents (18-21 years)
- **Search:** `N-acetylcysteine adolescent OR young adult`
- **Rationale:** Bridge between pediatric and adult dosing

## 2. Condition-Specific Searches

### Acetaminophen Overdose (Most Common Use)
- **Search:** `N-acetylcysteine acetaminophen overdose pediatric`
- **Rationale:** This is the most common indication; standard dosing protocols exist
- **Expected:** Well-established dosing regimens (likely IV: 150 mg/kg loading, then maintenance)

### Respiratory Conditions
- **Search:** `N-acetylcysteine cystic fibrosis pediatric`
- **Search:** `N-acetylcysteine bronchiolitis pediatric`
- **Rationale:** Different routes (inhaled/nebulized) and dosing

### Psychiatric Conditions (Beyond OCD/Trichotillomania)
- **Search:** `N-acetylcysteine autism pediatric`
- **Search:** `N-acetylcysteine ADHD pediatric`
- **Rationale:** May have different dosing patterns

## 3. Pharmacokinetic and Dose-Finding Studies

### PK Studies
- **Search:** `N-acetylcysteine pharmacokinetics pediatric`
- **Rationale:** Understanding absorption, metabolism, clearance in children

### Dose-Escalation Studies
- **Search:** `N-acetylcysteine dose escalation pediatric`
- **Search:** `N-acetylcysteine phase 1 pediatric`
- **Rationale:** Maximum tolerated dose, dose-limiting toxicities

## 4. Safety and Tolerability

### Safety Studies
- **Search:** `N-acetylcysteine safety pediatric`
- **Search:** `N-acetylcysteine adverse events pediatric`
- **Rationale:** Dose-related safety concerns

### Long-term Studies
- **Search:** `N-acetylcysteine long-term pediatric`
- **Rationale:** Chronic dosing safety and efficacy

## 5. Route-Specific Searches

### Inhaled/Nebulized
- **Search:** `N-acetylcysteine nebulized pediatric`
- **Search:** `N-acetylcysteine inhaled pediatric`
- **Rationale:** Different dosing for respiratory conditions

### Intravenous (Beyond Liver Failure)
- **Search:** `N-acetylcysteine IV pediatric`
- **Rationale:** Other IV indications may have different dosing

## 6. Formulation-Specific

### Different Formulations
- **Search:** `N-acetylcysteine effervescent pediatric`
- **Search:** `N-acetylcysteine sustained release pediatric`
- **Rationale:** Bioavailability differences

## 7. Comparative Studies

### Adult vs Pediatric
- **Search:** `N-acetylcysteine adult pediatric comparison`
- **Rationale:** Understanding age-related dosing differences

## 8. Specific Dosing Questions

### High-Dose Studies
- **Search:** `N-acetylcysteine high dose pediatric`
- **Rationale:** Safety of doses >2400 mg/day

### Low-Dose Studies
- **Search:** `N-acetylcysteine low dose pediatric`
- **Rationale:** Minimum effective doses

## 9. Special Populations

### Renal Impairment
- **Search:** `N-acetylcysteine renal impairment pediatric`
- **Rationale:** Dose adjustments needed

### Hepatic Impairment
- **Search:** `N-acetylcysteine hepatic impairment pediatric`
- **Rationale:** Metabolism considerations

## 10. Meta-Analyses and Reviews

### Systematic Reviews
- **Search:** `N-acetylcysteine pediatric systematic review`
- **Search:** `N-acetylcysteine pediatric meta-analysis`
- **Rationale:** Comprehensive dosing recommendations

## Priority Recommendations (Top 5)

1. **Acetaminophen Overdose** - Most common indication with established protocols
2. **Pharmacokinetics** - Critical for understanding age-appropriate dosing
3. **Neonates/Infants** - Significant gap in current data (youngest in current search: 6 months)
4. **Safety/Tolerability** - Essential for dose selection
5. **Cystic Fibrosis/Respiratory** - Different route (inhaled) with different dosing

